title: MRI and ¹⁸F-FDG PET/CT in monitoring the response to neoadjuvant chemotherapy: is it necessary to appropriately select the patients?
authors.affiliation: Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto (IOV - IRCCS), Via Gattamelata, 64 35128, Padova, Italy, laura.evangelista@tin.it.
authors.forename: Laura
authors.initials: L
authors.lastname: Evangelista
authors.forename: Domenico
authors.initials: D
authors.lastname: Ruggieri
authors.forename: Luigi
authors.initials: L
authors.lastname: Pescarini
authors.forename: Giorgio
authors.initials: G
authors.lastname: Saladini
mesh_terms: D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D044584:Carcinoma, Ductal / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed